Connection
Edward Yeh to C-Reactive Protein
This is a "connection" page, showing publications Edward Yeh has written about C-Reactive Protein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.010 |
|
|
|
-
Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005 Sep 20; 46(6):1112-3.
Score: 0.238
-
Yeh ET. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol. 2005 Sep; 28(9):408-12.
Score: 0.237
-
Yeh ET. C-reactive protein is an essential aspect of cardiovascular risk factor stratification. Can J Cardiol. 2004 Aug; 20 Suppl B:93B-96B.
Score: 0.220
-
Verma S, Szmitko PE, Yeh ET. C-reactive protein: structure affects function. Circulation. 2004 Apr 27; 109(16):1914-7.
Score: 0.216
-
Calabr? P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003 Oct 21; 108(16):1930-2.
Score: 0.207
-
Yeh ET, Palusinski RP. C-reactive protein: the pawn has been promoted to queen. Curr Atheroscler Rep. 2003 Mar; 5(2):101-5.
Score: 0.199
-
Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003 Jan 28; 107(3):370-1.
Score: 0.198
-
Yeh ET, Anderson HV, Pasceri V, Willerson JT. C-reactive protein: linking inflammation to cardiovascular complications. Circulation. 2001 Aug 28; 104(9):974-5.
Score: 0.179
-
Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000 Oct 31; 102(18):2165-8.
Score: 0.169
-
Calabro P, Yeh ET. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. Curr Hypertens Rep. 2008 Feb; 10(1):32-8.
Score: 0.070
-
Calabr? P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol. 2005 Nov; 20(6):541-6.
Score: 0.060
-
Willerson JT, Cable G, Yeh ET. PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. Tex Heart Inst J. 2009; 36(6):530-9.
Score: 0.019